On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support ...

Destiny 2's Revenant episode refreshed the Garden of Salvation loot pool, one of two raids without craftable weapons. While ...

The US is deploying its advanced THAAD missile system to Israel. The Terminal High Altitude Area Defense (THAAD) anti-missile ...

Bungie releases the patch notes for Destiny 2's Episode Revenant, detailing all of the buffs, nerfs, and general sandbox ...

Sage has decided to discontinue the development of dalzanemdor in Alzheimer’s disease. A study of the candidate in Huntington ...

Destiny 2 Episode Revenant brings big buffs to Stasis, meaning these often overlooked weapons absolutely deserve a second ...

Destiny 2 Episode Revenant is adding a lot of new weapons for players to use, and we’ve listed all of them coming in the ...

The company faced disappointment with the Phase 2 KINETIC study of SAGE-324 (BIIB124) in essential tremor, which failed to meet its primary endpoint. This setback, along with other recent pipeline ...

Sage Therapeutics, Inc. SAGE announced that partner Biogen BIIB has terminated its rights related to the investigational ...

The companies recently announced negative results from the Phase 2 KINETIC 2 Study of investigational SAGE-324 for the chronic treatment of essential tremor (ET) and discontinued further clinical ...

The companies recently announced negative results from the Phase 2 KINETIC 2 Study of investigational SAGE-324 for the chronic treatment of essential tremor (ET) and discontinued further clinical ...